Thank you to the numerous Milner affiliated companies who have been in contact to offer support to the University and NHS at this time.
Help tackle COVID-19 through research collaborations, by donating equipment or funding research
The University of Cambridge is co-ordinating activities to address COVID-19, including:
- Establishing research collaborations with other research institutions, industrial and charity partners across key disciplines and activities such as:
clinical trials, critical care, diagnostics, immunology, infectious diseases, public health, respiratory medicine, vaccines, virology, business risk, data science and modelling, engineering and manufacturing.
- Co-ordinating the donations of supplies, particularly personal protective equipment, for frontline health staff.
- Supporting the UK government initiative to manufacture ventilators.
Read more here about how your company may be able to help.
Cambridge-based volunteers for the 2020 COVID-19 crisis
A Cambridge-wide information gathering exercise is being undertaken (supported by a growing number of Cambridge departments, institutes, companies, organisations etc.) to identify staff with skills that might be of use in COVID-19 research and/or diagnostic testing.
Funding for Covid-19 research
A number of funding calls have been initiated for researchers and companies working on therapeutics and diagnostics for coronaviruses:
Wellcome Trust seed funding to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity. To learn more, email email@example.com
LifeArc funding for the development and testing of therapeutics to treat COVID-19. LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run trials in patients during the current epidemic.
Innovative medicines initiative (IMI) call for development of therapeutics and diagnostics combatting coronavirus infections.